Aptevo Therapeutics (NASDAQ:APVO) just reported results for the fourth quarter of 2023.
- Aptevo Therapeutics reported earnings per share of -4 cents. This was above the analyst estimate for EPS of -41 cents.
- The company did not report any revenue for the quarter.